Gen-Wealth Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$539K Sell
2,268
-189
-8% -$39.3K 0.15% 127
2026
Q1
$519K Buy
2,457
+237
+11% +$51K 0.16% 129
2025
Q4
$456K Sell
2,220
-1,040
-32% -$196K 0.15% 143
2025
Q3
$512K Sell
3,260
-255
-7% -$39.4K 0.17% 143
2025
Q2
$591K Sell
3,515
-976
-22% -$145K 0.23% 109
2025
Q1
$619K Sell
4,491
-409
-8% -$52.1K 0.26% 102
2024
Q4
$579K Sell
4,900
-109
-2% -$12.7K 0.25% 102
2024
Q3
$540K Buy
5,009
+320
+7% +$33.5K 0.24% 118
2024
Q2
$461K Buy
4,689
+585
+14% +$59.6K 0.22% 116
2024
Q1
$459K Buy
+4,104
New +$443K 0.23% 112

Other funds holding CAH

Gen-Wealth Partners's CAH Position: Q2 2026 in Review

Gen-Wealth Partners reduced its Cardinal Health (CAH) stake by 7.7% in Q2 2026, selling an estimated $39.3K and leaving 2,268 shares worth $539K. The position accounts for 0.15% of the portfolio, ranked #127.

Gen-Wealth Partners first reported a position in CAH in Q1 2024 and has held it in 10 quarters since. The position peaked at $619K in Q1 2025. 902 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Gen-Wealth Partners held 2,268 shares of Cardinal Health worth $539K as of Q2 2026.
  • Gen-Wealth Partners sold 189 Cardinal Health shares in Q2 2026, an estimated $39.3K.
  • Cardinal Health made up 0.15% of Gen-Wealth Partners's portfolio in Q2 2026, its #127 holding.
  • Gen-Wealth Partners first reported a position in Cardinal Health in Q1 2024 and has held it in 10 quarters since.
  • Gen-Wealth Partners's Cardinal Health position peaked at $619K in Q1 2025.
  • 902 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.